Rating History for Cellular Biomedicine Group (CBMG) by Baird
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/13/2020 | Madhu Kumar | Downgrade | Neutral (Outperform) |
19.00 (N/A) |
14.27 (19.75) |
38.4% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/13/2020 | Madhu Kumar | Downgrade | Neutral (Outperform) |
19.00 (N/A) |
14.27 (19.75) |
38.4% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||